Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

23 recalls · Class III, newest first

Class III · Low risk

3M ESPE Clinpro 5000

Labeling: Incorrect or Missing Lot and/or Exp. Date - The subject lot is missing the lot number and expiration date stamp on the primary box..

Terminated Labeling / mix-up 3M Company/3m Espe Dental Products NDC 48878-3130-04 D-0376-2015
Class III · Low risk

BELVIQ¿ (Lorcaserin HCl)

Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.

Terminated Labeling / mix-up Eisai Inc D-0302-2015
Class III · Low risk

Fluoxetine Capsules USP

Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.

Terminated Labeling / mix-up Sandoz Incorporated NDC 0781-2822-01 D-0291-2015
Class III · Low risk

Clonidine HCl Injection

Labeling: Label Error On Declared Strength: The side label description incorrectly states "Each mL contains 500 mcg Clonidine Hydrochloride" instead of stating "Each mL contains 100 mcg Clonidine Hydrochloride".

Terminated Labeling / mix-up X-Gen Pharmaceuticals Inc. NDC 39822-2000-1 D-1444-2014
Class III · Low risk

VIRACEPT (nelfinavir mesylate)

Labeling: Incorrect or missing lot and or Exp Date: The bottles were labeled with an incorrect expiry date 11/2016. The correct expiry date is 09/2016.

Terminated Labeling / mix-up Pfizer Inc. NDC 63010-027-70 D-1443-2014
Class III · Low risk

Vasotec (enalapril maleate)

Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.

Terminated Labeling / mix-up Valeant Pharmaceuticals North America LLC NDC 0187-0140-90 D-0019-2015
Class III · Low risk

Oasis TEARS

Labeling: Missing Label; The label on the immediate bottle is missing.

Terminated Labeling / mix-up Oasis Medical Inc D-1347-2014
Class III · Low risk

Triveen - PRx RNF Capsules

Labeling: Not Elsewhere Classified: Label indicates that the product contains Vitamin B12 (12 micrograms) on the Supplement Facts panel, however, the formulation of this product does not contain Vitamin B12.

Terminated Labeling / mix-up Trigen Laboratories, Inc. NDC 13811-558-30 D-1544-2014
Class III · Low risk

Oxandrolone Tablets

Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper, labeled with the correct shipper bar code label, sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.

Terminated Labeling / mix-up Upsher Smith Laboratories, Inc. NDC 0245-0272-06 D-1255-2014
Class III · Low risk

Mercaptopurine Tablets USP

Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the filed 24 months.

Terminated Labeling / mix-up Boehringer Ingelheim Roxane Inc NDC 0054-4581-11 D-1314-2014
Class III · Low risk

Azathioprine Tablets USP

Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the filed 24 months.

Terminated Labeling / mix-up Boehringer Ingelheim Roxane Inc NDC 0054-4084-25 D-1313-2014
Class III · Low risk

Psyllium Fiber

Labeling: Label Error on Declared Strength; Listed active ingredient strength is inaccurate.

Terminated Labeling / mix-up Konsyl Pharmaceuticals Inc D-1315-2014
Class III · Low risk

Demerol

Labeling; Missing label; ampoules are missing the immediate container label

Terminated Labeling / mix-up Hospira Inc. NDC 0409-1203-01 D-1226-2014
Class III · Low risk

Polidocanol 1% Solution

Labeling: Incorrect Expiration Date; Expiration date is earlier than listed on vial.

Terminated Labeling / mix-up John W Hollis Inc D-1259-2014
Class III · Low risk

Papaverine 60 mg

Labeling: Incorrect Expiration Date; Expiration date is earlier than listed on vial.

Terminated Labeling / mix-up John W Hollis Inc D-1258-2014
Class III · Low risk

Ritalin HCl

Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although t

Terminated Labeling / mix-up Novartis Pharmaceuticals Corp. NDC 0078-0441-05 D-1228-2014
Class III · Low risk

Ritalin HCl

Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although t

Terminated Labeling / mix-up Novartis Pharmaceuticals Corp. NDC 0078-0440-05 D-1227-2014
Class III · Low risk

Triamcinolone Acetonide Cream USP

Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.

Terminated Labeling / mix-up Fougera Pharmaceuticals Inc. NDC 0168-0004-80 D-1152-2014

Recalls by year